Longevity & Aging · Metabolic & Cardiometabolic
high dietary protein leucine causes atherosclerosis via macrophage mTORC1 activation
In plain terms: Does eating a lot of protein clog arteries through a leucine/mTOR pathway?
Contested Longevity & Aging 🔬 Includes disconfirming
Part of: • ApoB & Lipid Longevity
RefutedContestedStrong support
consensus score -0.04
Real, well-characterized mechanism with a leucine threshold and some human monocyte/macrophage data — but the atherosclerosis outcome itself is shown only in mice; there is NO human cardiovascular-endpoint trial.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
6 support 2 contradict 3 tested null 7 mixed · 18 sources, 8 independent groups
The evidence (18)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Inao 2026 · Clin Nutr ESPEN | observational | mixed | low | Cohort of chronic heart failure patients found animal vs plant protein intakes had differing associations with mortality/hospitalization, a diseased HF population not testing atherosclerosis onset. |
| Zhang 2025 · Autophagy | animal | supports | moderate | Follow-up confirms dose-dependent leucine-mTOR threshold in human monocytes/macrophages and atherosclerosis acceleration in mice; frames therapeutic target — still no human clinical endpoint. |
| Linde 2026 · Br J Nutr | observational | contradicts | moderate | Prospective African cohort (1737 adults, 13y) found higher animal protein intake associated with LOWER all-cause mortality and no significant association with CVD mortality. |
| Gribbin 2022 · Heart | observational | tested-null | moderate | Australian women's cohort found dietary macronutrient (including protein) associations with CVD were inconsistent/weak, a null-to-mixed cohort data point on protein and cardiovascular disease. |
| Bonacina F et al 2025 · study_type: mechanism | mechanism | supports | high | Nature Reviews Cardiology piece on lysosomes as nutrient/mTORC1 sensing hubs in macrophage immunometabolic reprogramming in atherosclerosis; entirely mechanistic (cell biology), states mTORC1 signaling shapes macrophage cholesterol handling |
| Starling-Soares B et al 2026 · study_type: mechanism | mechanism | mixed | moderate | Review of BCAA and inflammation in obesity/diabetes (not atherosclerosis-specific); explicitly states current evidence 'cannot identify a causative role' for BCAAs in inflammation, usually requiring a prior/concomitant stimulus — human and |
| Yang 2024 · Am J Chin Med | animal | supports | low | ApoE-/- mouse study showed enhancing autophagy by inhibiting PI3K/Akt/mTOR reduced atherosclerotic lipid accumulation, corroborating the mTOR-autophagy axis mechanistically (pharmacologic, not protein). |
| Paik 2020 · Nutrients | observational | mixed | moderate | Korean prospective cohort found high protein-to-carbohydrate ratio associated with increased metabolic syndrome/triglycerides/fasting glucose in men only, an indirect cardiometabolic signal not atherosclerosis per se. |
| Wang 2025 · PLoS One | animal | tested-null | low | In ApoE-/- mice suppressing the PI3K/Akt/mTOR pathway reduced atherosclerotic plaque, supporting macrophage mTOR as atherogenic but via drug inhibition, not dietary leucine. |
| Müller JS et al 2026 · study_type: mechanism | animal | supports | moderate | Systematic review of 162 publications/76 kinases in macrophage atherogenesis; mTOR-adjacent kinases (Akt1, CaMK family) drive foam-cell formation and necrotic core expansion, purely mechanistic/animal-and-cell-line synthesis, no human outco |
| Li J et al 2026 · study_type: mechanism | observational | mixed | moderate | Review of BCAA/leucine-mTORC1 signaling in chronic disease including CVD, human evidence framed as 'accumulating association' not causal proof, no atherosclerosis-specific numbers given. |
| Mantzouranis 2023 · Nutrients | meta-analysis | contradicts | moderate | Meta-analysis of 14 prospective cohorts found no significant association between high vs normal protein intake and cardiovascular mortality or events in adults without CVD. |
| Song 2016 · JAMA Intern Med | observational | mixed | high | Two large US cohorts found higher animal protein associated with modestly higher CVD mortality mainly among people with lifestyle risk factors, while plant protein was inversely associated. |
| Bell 2025 · Nutr Res Rev | mechanism | mixed | moderate | Narrative review of whey protein RCTs found acute BCAA/leucine elevations but inconsistent chronic glycemic effects, supporting the leucine-elevation step but not a demonstrated leucine-atherosclerosis link in humans. |
| Jankovic 2015 · Am J Clin Nutr | observational | tested-null | moderate | Pooled analysis of elderly European/US cohorts found adherence to WHO protein targets was not clearly related to CVD mortality, no cohort signal that high protein drives cardiovascular death in older adults. |
| Zhang 2024 · Nat Metab | animal | supports | high | Human feeding studies show leucine activates macrophage mTOR above about 25g protein/meal; atherosclerosis itself demonstrated in mice fed greater than about 22% energy as protein — mechanism human, hard outcome murine. |
| Wu Y et al 2024 · study_type: mechanism | observational | mixed | moderate | Review focused specifically on L-leucine, L-arginine, L-glutamine regulating autophagy in atherogenesis via amino-acid-sensing pathways (mTORC1 is the master amino-acid sensor for autophagy); entirely mechanistic/cell-biology synthesis, no |
| Shen R et al 2025 · study_type: mechanism | observational | supports | low | Review states 'elevated BCAA levels are associated with atherosclerosis development' via immunometabolic reprogramming affecting macrophages/T/B cells in coronary heart disease; draws on animal and human observational data but reports no sp |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.